positive
1h agoNephroPlus gains SEBI clearance for ₹353 crore IPO to expand dialysis network

Healthcare services provider NephroPlus secured SEBI approval to raise ₹353 crore through an initial public offering aimed at expanding its dialysis center network across India and international markets. Proceeds will fund new centers in Tier-2 cities and support technology upgrades in clinical operations. The Hyderabad-based company currently manages over 300 dialysis centers and serves 22,000 patients monthly.
The IPO is expected to enhance liquidity and deepen NephroPlus’s presence in the specialty healthcare segment amid rising chronic kidney disease burden globally.
Explore:Mutual Fund Categories
positive
1h agoNephroPlus gains SEBI clearance for ₹353 crore IPO to expand dialysis network

Healthcare services provider NephroPlus secured SEBI approval to raise ₹353 crore through an initial public offering aimed at expanding its dialysis center network across India and international markets. Proceeds will fund new centers in Tier-2 cities and support technology upgrades in clinical operations. The Hyderabad-based company currently manages over 300 dialysis centers and serves 22,000 patients monthly.
The IPO is expected to enhance liquidity and deepen NephroPlus’s presence in the specialty healthcare segment amid rising chronic kidney disease burden globally.
Explore:Mutual Fund Categories
about 2 hours ago
1 min read
79 words

NephroPlus received SEBI approval for a ₹353 crore IPO to expand dialysis centers and modernize technology across India and international markets.
Healthcare services provider NephroPlus secured SEBI approval to raise ₹353 crore through an initial public offering aimed at expanding its dialysis center network across India and international markets. Proceeds will fund new centers in Tier-2 cities and support technology upgrades in clinical operations. The Hyderabad-based company currently manages over 300 dialysis centers and serves 22,000 patients monthly.
The IPO is expected to enhance liquidity and deepen NephroPlus’s presence in the specialty healthcare segment amid rising chronic kidney disease burden globally.

Healthcare services provider NephroPlus secured SEBI approval to raise ₹353 crore through an initial public offering aimed at expanding its dialysis center network across India and international markets. Proceeds will fund new centers in Tier-2 cities and support technology upgrades in clinical operations. The Hyderabad-based company currently manages over 300 dialysis centers and serves 22,000 patients monthly.
The IPO is expected to enhance liquidity and deepen NephroPlus’s presence in the specialty healthcare segment amid rising chronic kidney disease burden globally.
Companies:
NephroPlus
Tags:
ipo
nephroplus
ipo
nephroplus
healthcare
fundraising
sebi
Nov 11, 2025 • 15:39 IST